No Data
No Data
Volume change rate ranking (9 o'clock) - Takase, Koyo Corporation, etc. ranked in.
In the volume change rate ranking, by comparing the average volume over the last five days with the volume on the distribution day, one can understand the trends of selection and the interests of market participants. ■ Top volume change rates [As of December 4, 9:32] (Comparison of the average volume over the last five days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <9087> Takase 200142.92 400% 0% <7946> Koyo Co. 210084.98 357.11%
December 4th [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 JCR Pharma <4552> 727 yen (12/3) Human growth hormone preparation is the main product. The company announced that the first dose was administered to the first subject in the phase 1/2 clinical trial targeting mucopolysaccharidosis type 3B (MPS3B) in Japan for the blood-brain barrier penetrating α-N-acetylglucosaminidase preparation (JR-446) it developed. MPS3B is being co-developed and marketed with Medipal Holdings <7459>.
Focus on JCR Pharma and ABC Mart, while Uchida Yoko and Tsukishima HD are sluggish.
In the US stock market on the 3rd of yesterday, the dow jones industrial average closed down by $76.47 at 44,705.53, the nasdaq composite index rose by 76.96 points to 19,480.91, and the Chicago nikkei 225 futures were up by 90 yen compared to the Osaka daytime, at 39,240 yen. The exchange rate was 1 dollar = 149.50-150.00 yen. In today's Tokyo market, ABC Mart <2670> reported an increase in same-store sales of 14.7% in November, up from an increase of 6.3% in October, while another company also reported an increase in same-store sales of 8.9% in November and 6.3% in October.
Japan Machinery Orders Decline 2.9% in September
Takakita: Semi-Annual Report - Term 81 (2024/04/01 - 2025/03/31)
Takakita: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
No Data